Oncology Biotech Updates This Week: $12B+ M&A Wave, Kite Pharma CAR-T Approval, and AI-Driven Deals Reshape the Sector
✦ NabkaNews BriefAuto-summarized from multiple outlets · verify with the source
There has been significant activity in the oncology biotech sector, with a wave of mergers and acquisitions valued at over $12 billion. Kite Pharma has received approval for a CAR-T treatment. The sector is also seeing changes driven by artificial intelligence-related deals.